RED SREDs-SwedenNCT06371963
Relative Energy Deficiency in Sports (REDs) in Swedish Athletes
An observational study of RED S and Eating Disorders, run by Linnaeus University at 1 site in Sweden.
Trial summary
Background: Relative Energy Deficiency in Sport (REDs) describes impairment of health and performance due to problematic (long-term/severe) low energy availability (LEA), with or without eating disorders. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- RED S, Eating Disorders
- How many people
- 44 participants
- Where
- 1 siteSweden
- Study dates
- 10 May 2022to 30 May 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Swedish male and female national team athletes and gender- and age matched controls.
Who may be able to join
- National-team level athletes
- Non-elite athletic controls
Who cannot join
- chronic illness (e.g., diabetes, hypothyroidism)
- injury
- smoking
- pregnancy
- hormonal contraceptive use
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Relative Energy Deficiency in Sports (REDs) in Swedish Athletes Study
Background: Relative Energy Deficiency in Sport (REDs) describes impairment of health and performance due to problematic (long-term/severe) low energy availability (LEA), with or without eating disorders. LEA is frequently reported in sports with high training volumes, especially in leanness demanding sports, and 20% of female and 9% of male Norwegian national team athletes have been reported to have eating disorders. Potential trigger factors are e.g., dieting, injuries, coaching behavior, and subculture aspects e.g., focus on low body weight. The main questions that will be addressed are: 1. What is the prevalence of eating disorders and REDs among Swedish elite athletes and controls? 2. What is the impact of problematic LEA on health and performance aspects in both male and female athletes? Methods: National team athletes and gender and matched controls will be invited to an anonymous on-line survey. Elite athletes who agree to participate, will be invited to assessment of eating disorders, nutritional and physiological status (e.g., metabolic and endocrine markers, bone health, microbiota, dietary intake, energy availability, and performance).
Read the detailed description
The syndrome of REDs describes impairment of physiological functions e.g., reproduction and bone health with negative impact on performance. The etiology behind is problematic low energy availability (LEA), defined as low energy intake relative to exercise energy expenditure relative to fat free mass. Eating disorders can either proceed or result from REDs. LEA induces metabolic and endocrine alterations, and energy balance at a lower level prevents further weight-loss. Therefore, most athletes with LEA have a body weight within the normal range, and low resting metabolic rate is a recognized LEA surrogate marker.
LEA suppresses anabolic hormones e.g. estradiol/testosterone, while cortisol levels increase, and bone formation markers are reduced. Low testosterone levels have been reported in male endurance athletes, with potential negative effects on fertility. Among Irish male athletes from different sports 23% were identified with low libido and associated with increased injury risk. Menstrual disturbances due to LEA is frequently reported, and is associated with low bone mineral density and injuries.
Glucose is an important substrate for the muscles and an essential substrate for brain neurons and immune cells. Low glucose availability is considered a major trigger to the alterations of the hypothalamic-pituitary axis hormones causing suppression of the sex and thyroid hormones and increase in cortisol. Blood glucose homeostasis is therefore protected with several mechanism (hepatic gluconeogenesis, increased lipolysis and ketogenesis) during prolonged LEA. Hence, hypoglycemia is a marker of a prolonged and severe catabolic state.
LEA has been associated with gastrointestinal problems in female athletes, derived from hormonal and dietary factors affecting motility and digestion. Long-term LEA in patients with anorexia nervosa is associated with profound alterations of the gut microbiome, with negative impact on gastrointestinal function and immunologic processes, and a reduced microbial diversity is therefore suggested as a potential useful biomarker of REDs in athletes. It is therefore relevant to investigate the associations between the gut microbiome, Gastrointestinal function and immunology status in athletes with and without clinical indication of LEA.
LEA affects both men and women, athletes as well as recreational active people however, the threshold and endocrine response seem to differ between gender. Although menstrual disturbances has been frequently reported in female athletes for decades, few studies have investigated the impact on performance, and no study has yet investigated the performance effects of low libido in male athletes. Furthermore, no study has investigated microbial diversity in male and female athletes with clinical symptoms of LEA. Therefore, it is highly relevant to investigate aspects of physiology, nutrition, performance, and sport environment regarding REDs and eating disorders in both male and females.
Objective: The aims of the study are to investigate the prevalence of athletes at risk of eating disorders and REDs among Swedish athletes and controls, and to investigate physiological aspects of elite athletes with and without problematic LEA. Furthermore, to investigate if there is a difference in nutritional status (metabolic and endocrine markers, iron- vitamin D status, energy availability, glucose homeostasis, resting metabolic rate, body composition including bone mineral density), gut microbiota (including associations to immunity), immune function, and performance, in athletes diagnosed with REDs according the International Olympic Committee REDs Clinical Assessment Tool vs. gender matched athletes without REDs. An additional aim is to evaluate if problematic LEA affects biological markers in the biological passport also called "Athlete Biological Passport" in anti-doping.
Methodology and plan of work National senior team and recruiting squad athletes from Swedish sport federations will be invited to an anonymous on-line survey. The 20 minute on-line survey includes: Eating Disorder Examination Questionnaire (EDE-Q). An EDE-Q global score ≥ 2.3 for females and ≥ 1.68 for males indicate risk of EDs; Exercise Addiction Inventory (EAI). A total EAI-score 24-30 indicate compulsive exercise; LEA in Females Questionnaire (LEAF-Q) and LEA in Males Questionnaire (LEAM-Q) to categorize athletes ar risk of LEA; Major Depression Inventory (MDI) to detect depression symptoms; Swedish Acceptance and Action Questionnaire (SAAQ) to assess psychological flexibility; and Motivation to Change Questionnaire (MCQ) to asses the ability for behavioral changes.
Participants who are interested in participating in an on-line diagnostic eating disorder examination interview (the EDE-16) and/or physiological testing, provide their name, cell-phone number, and e-mail address after completing the online survey, and will thereafter be invited to the sport physiology lab for the next phase of the study (physiological assessments).
On the day of the physiological examination, the participants will be asked to deliver a fecal sample. Gut microbiota composition bacterial DNA will be sequenced using next-generation sequencing of microbial genes.
Fasting resting metabolic rate will be measured, using a ventilated open hood system. The ration between measured and predicted resting metabolic will be calculated, and low resting metabolic rate will be defined as resting metabolic rate ratio < 0.90.
Blood samples will be collected and stored (-80°) for later analyses according to standard laboratory procedures (e.g. iron- and vitamin D status, hormones, metabolic, bone and immune markers).
Body weight, height (fixed stadiometer), fat free mass, fat mass and bone mineral density (whole body, femur, and lumbar spine) will be measured using dual-energy x-ray absorptiometry. Low bone mineral density will be defined as Z score -1 to -2 in at least one measured site and osteoporosis as Z-score ≤-2.
After a standardized meal and warm up, a bicycle ergometer exercise test will be performed (6 minutes at 50 watt, followed by 12-14 watt per minute increased workload until exhaustion). Heart rate and an air-tight mask covering the mouth and nose will be used to measure peak oxygen uptake. Capillary lactate will be drawn before, direct after and 5 minutes after the test. Explosive lower body power will be assessed through a counter movement jump-test. Isometric mid-thigh pull will be performed to assess whole body strength and force production. A Wingate-test will be performed to assess muscular power and anaerobic capacity. Post exercise blood-samples will be drawn and stored (-80°) for later analyses according to standard laboratory procedures (e.g., immune markers).
Participants will be asked to wear a subcutaneous continuous blood glucose monitor, an accelerometer, throughout the day except during training where they will wear heart rate monitors and register all training sessions in their home environment for 7 consecutive days. During 4 days in the the same period they will be asked to register all food intake using an electronic kitchen scale and an on-line nutrient program while information of energy and nutrient intake is blinded for the participants. Energy and nutrient intake will be calculated using a nutrient analysis program. Training heart rate and training logs will be used to assess exercise energy expenditure based on individual prediction equations from measured heart rate and corresponding energy expenditure during the peak oxygen uptake test. Energy availability will be calculated by subtracting mean exercise energy expenditure from mean energy intake relative to fat free mass.
Eumenorrheic athletes will be tested on day 2-6 of menstruation, while other athletes will be tested when convenient. All materials (electronic kitchen scale, heart rate monitor, fecal sample collective tube and a prepaid security envelops for returning materials) will be provided.
The skills and equipment for all assessments are available at the Linnaeus University including preparation, storage, and analysis of blood. Fecal samples will be analyzed at the Department of Nutrition, Exercise and Sport, University of Copenhagen.
Power calculation: to provide 80% power to detect a clinically relevant difference in sex hormones a minimum of 14 females (estradiol standard deviation 79.0 nmol/L) and 8 males (total testosterone standard deviation 7.4 pmol/L) in each group will be included.
Recruitment will be performed via the Swedish Olympic Committee, the national sport federations, and social media. The on-line surveys will be launched via the REDs Sweden project webpage and will be open March 2023 to June 2024. Recruitment of age and gender matched controls to the online survey will be performed via social media. Athletes who agree to participate in physiological testing will be continuously scheduled for tests and assessments.
Ethical reviews: The study will follow the checklist issued by the national committees for research ethics and the Helsinki Declaration. Ethical approval has been approved (2021-07031-01). All information and results will be coded (anonymized) before analysis and stored according the general data protection regulation. A list with codes connecting participant names and information will be kept safely locked in by the principal investigator at the Linnaeus University. There are no expected risks with participation. The radiation during the Dual-energy X-ray absorptiometry measurement is negligible. Participants may feel uncomfortable during the assessment of resting metabolic rate and blood sampling. The study collaborators will make sure that participants feel safe during all measurements. If a diagnosis is identified, participants will be referred to the health care system. Participants will be informed regarding ethical rights, the project, expected time cost for participation, and feedback on individual results.
- Conditions
- RED S, Eating Disorders
- Keywords
- Observational study, REDs, Eating disorders, Cross-sectional study, Elite athletes, Sweden, Physiological assessments, Performance, Microbiota, Immune function, Resting metabolic rate, Energy availability, Biomarkers, Reproductive dysfunction, The biological passport, Exercise addiction, Gastrointestinal function
- Medical subject headings
- Relative Energy Deficiency in Sport, Feeding and Eating Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Elite Athletes | Senior Swedish male and female national team and recruiting squad athletes. | |
| Gender and age matched controls | Healthy male and female non-elite athletic controls. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-reported eating disorders
Participants: Female and male elite athletes and age and gender matched controls.
An on-line version of the Eating Disorder Examination Questionnaire (EDE-Q) will be used comprising of 28 items, 4 sub-scales (restrained eating, eating-, body-, and weight concerns), and a global score. An EDE-Q global score ≥ 2.3 for females and ≥1.7 for males indicate risk of eating disorder.
Measured: Day one
Secondary outcomes (23)
Eating disorders
Participants: Elite athlete and controls.
Diagnostic interview using the eating disorder examination (EDE-16).
Measured: Through study completion, an average of 1 year
Self-reported reproductive function in females not using hormonal contraceptives
Participants: Elite athletes and controls.
The Low Energy Availability in Females Questionnaire (LEAF-Q) comprises 25 items divided into 4 variables: 1) gastrointestinal symptoms, 2) injuries, 3) hormonal contracptives and 4) menstrual function that are scored on a Likert scale (0-46). The higher the score the higher risk of gastrointestinal dysfunction, injuries and menstrual dysfunction.
Menstrual cycle lengths ≥ 21 days and ≤ 35 days resulting in 9 or more consecutive periods per year indicate eumenorrhea plus results from outcome 4.
Primary amenorrhea: No menarche by age 15 years Oligomenorrhea: menstrual cycle length > 35 days plus results from outcome 4. Secondary amenorrhea: absence of ≥ 3 consecutive menstrual bleedings. No menarche or no menstrual bleeding the last 3 months plus results from outcome 4.
Measured: Day one
Reproductive function in females not using hormonal contraceptives
Participants: Female elite athletes (n=28).
Eumenorrhea: evidence of luteinizing hormone surge, and estrogen, androgen and prolactin levels within normal reference range plus correct categorization by outcome 3.
Oligomenorrhea and secondary amenorrhea: androgens and prolactin levels within normal reference range plus correct categorization from outcome 3.
Measured: Through study completion, an average of 1 year
Self-reported reproductive function in males
Participants: Elite athletes and controls.
Low Energy Availability in Males Questionnaire (LEAM-Q) comprising of 4 items regarding libido. A low sex drive score is generated by using scores equal or greater than 2 on "Sex drive in general" or equal or greater than 2 on "The number of morning erections" and equal or greater than 1 for "Morning erections compared to normal" to represent reproductive dysfunction plus results from outcome 6.
Measured: Day one
Reproductive function in males
Participants: Male athletes (n=16).
Total and free testosterone levels in the rested and fasted state. Clinically low levels or levels within the lowest quartile of reference range is indicative of hypogonadotropic hypogonadism plus results from outcome 5.
Measured: Through study completion, an average of 1 year
Gastrointestinal function
Participants: Elite athletes and controls.
The LEAF-Q variable regarding gastrointestinal function will be used (se Outcome 5).
Measured: Day one
Injury
Participants: Elite athletes and controls.
The LEAF-Q variable regarding injury will be used (see Outcome 5).
Measured: Day one
Self- reported symptoms of depression
Participants: Elite athletes and controls.
Symptoms of depression will be assessed using the Major Depression Index comprising of 10 items that are rated on a 6-point Likert scale from 0 (no time) to 5 (all the time). The total score ranges from 0 to 50 where a higher score reflects more symptoms of depression. Recommended cut-off points are 21 for mild depression, 26 for moderate depression, and 31 for severe depression.
Measured: Day one
Compulsive exercise
Participants: Elite athletes and controls.
Compulsive exercise will be assessed using the Exercise Addiction Inventory that covers six core symptoms of behavioral addictions. Each item is scored on a Likert-scale from 1 (strongly disagree) to 5 (strongly agree) and a total score of >23 indicates high risk of addiction.
Measured: Day one
The motivation for behavioral changes
Participants: Elite athletes and controls.
The motivation for behavioral cahnges will be assesed by the Motivation to Change Questionnaire comprising 54 items scored on Likert scales where a higher core indicates poorer ability for behavioral changes.
Measured: Day one
Psychological flexibility
Participants: Elite athletes and controls.
Psychological flexibility will assessed using the Swedish Acceptance and Action Questionnaire that comprises of 6 items that are scored on a Likert scales (0-6). The higher the score the poorer psychological flexibility.
Measured: Day one
Changes in immune markers from pre to post exercise
Participants: female athletes (n=28) and male athletes (n=16).
Inflammatory cytokines and immune components will be assessed in the fasted and rested state and post and exercise test.
Measured: Through study completion, an average of 1 year
Microbiota
Participants: female athletes (n=28) and male athletes (n=16).
Fecal sample, next-generation sequencing of microbial 16S rRNA genes analyzing bacterial diversity, and composition.
Measured: Through study completion, an average of 1 year
Dietary intake
Participants: female athletes (n=28) and male athletes (n=16).
A 4-day weighed dietary registration using an electronic kitchen scale and an on-line nutrient program.
Measured: Through study completion, an average of 1 year
Maximal aerobic capacity
Participants: female athletes (n=28) and male athletes (n=16).
Maximal aerobic capacity (VO2peak) will be assessed by a bicycle ergometer exercise test using a heart rate monitor, an air-tight mask covering the mouth and nose and the Vyntus CPX system.
Measured: Through study completion, an average of 1 year
Explosive lower body power
Participants: female athletes (n=28) and male athletes (n=16).
Explosive lower body power will be assessed by a counter movement jumping test.
Measured: Through through study completion, an average of 1 year
Whole body strength
Participants: female athletes (n=28) and male athletes (n=16).
Whole body-strength and force production will be assessed by an isometric mid-thigh pull test.
Measured: Through study completion, an average of 1 year
Muscular power
Participants: female athletes (n=28) and male athletes (n=16).
Wingate-test (cycles at maximal effort for 30 seconds) will be performed to assess muscular power and anaerobic capacity.
Measured: Through study completion, an average of 1 year
Resting Metabolic Rate
Participants: female athletes (n=28) and male athletes (n=16).
Resting metabolic rate (kcal/day) will be measured using indirect calometry by a ventilated open hood system (Vyntus CPX).
Measured: Through study completion, an average of 1 year
Body composition
Participants: female athletes (n=28) and male athletes (n=16).
Fat free mass, fat mass and whole-body, femur and lumbar spine bone mineral density, will be assessed by dual-energy x-ray absorptiometry.
Measured: Through study completion, an average of 1 year
Body weight
Participants: female athletes (n=28) and male athletes (n=16).
Body mass will be assessed using bioimpedance (Inbody 700)
Measured: Through study completion, an average of 1 year
Body height
Participants: female athletes (n=28) and male athletes (n=16).
Height will be assessed using a stadiometer.
Measured: Through study completion, an average of 1 year
Glucose levels
Participants: female athletes (n=28) and male athletes (n=16).
Continuous glucose monitoring using the device by Dexcom.
Measured: Through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2024
- Study start10 May 2022
- Primary completion30 May 2024
- Study completion30 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (19)Papers the sponsor has linked to this study.
- Other trials for RED SStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Linnaeus University
- Sponsor type
- University, hospital or other
- Collaborators
- Swedish Olympic Committee, Swedish Research Council for Sport Science, World Anti-Doping Agency
- Responsible party
- Principal investigator, Anna Melin, Linnaeus University
- Investigators
- Anna Melin, PhD, Principal investigator, Linnaeus University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06371963
- Sponsor's protocol ID
- LinnaeusU REDs
- Acronym
- REDs-Sweden
- Status last verified
- May 2024
- First submitted
- 26 Feb 2024
- Last updated
- 10 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, Heikura IA, Melin A, Pensgaard AM, Stellingwerff T, Sundgot-Borgen JK, Torstveit MK, Jacobsen AU, Verhagen E, Budgett R, Engebretsen L, Erdener U. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023 Sep;57(17):1073-1097. doi: 10.1136/bjsports-2023-106994.
PubMed 37752011Melin A, Tornberg AB, Skouby S, Moller SS, Sundgot-Borgen J, Faber J, Sidelmann JJ, Aziz M, Sjodin A. Energy availability and the female athlete triad in elite endurance athletes. Scand J Med Sci Sports. 2015 Oct;25(5):610-22. doi: 10.1111/sms.12261. Epub 2014 May 30.
PubMed 24888644Mountjoy M, Sundgot-Borgen JK, Burke LM, Ackerman KE, Blauwet C, Constantini N, Lebrun C, Lundy B, Melin AK, Meyer NL, Sherman RT, Tenforde AS, Klungland Torstveit M, Budgett R. IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. Br J Sports Med. 2018 Jun;52(11):687-697. doi: 10.1136/bjsports-2018-099193. No abstract available.
PubMed 29773536Heikura IA, Uusitalo ALT, Stellingwerff T, Bergland D, Mero AA, Burke LM. Low Energy Availability Is Difficult to Assess but Outcomes Have Large Impact on Bone Injury Rates in Elite Distance Athletes. Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):403-411. doi: 10.1123/ijsnem.2017-0313. Epub 2018 Jun 12.
PubMed 29252050Lundy SD, Sangwan N, Parekh NV, Selvam MKP, Gupta S, McCaffrey P, Bessoff K, Vala A, Agarwal A, Sabanegh ES, Vij SC, Eng C. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur Urol. 2021 Jun;79(6):826-836. doi: 10.1016/j.eururo.2021.01.014. Epub 2021 Feb 8.
PubMed 33573862Hackney AC, Lane AR, Register-Mihalik J, O'leary CB. Endurance Exercise Training and Male Sexual Libido. Med Sci Sports Exerc. 2017 Jul;49(7):1383-1388. doi: 10.1249/MSS.0000000000001235.
PubMed 28195945Logue DM, Madigan SM, Melin A, Delahunt E, Heinen M, Donnell SM, Corish CA. Low Energy Availability in Athletes 2020: An Updated Narrative Review of Prevalence, Risk, Within-Day Energy Balance, Knowledge, and Impact on Sports Performance. Nutrients. 2020 Mar 20;12(3):835. doi: 10.3390/nu12030835.
PubMed 32245088Seitz J, Belheouane M, Schulz N, Dempfle A, Baines JF, Herpertz-Dahlmann B. The Impact of Starvation on the Microbiome and Gut-Brain Interaction in Anorexia Nervosa. Front Endocrinol (Lausanne). 2019 Feb 12;10:41. doi: 10.3389/fendo.2019.00041. eCollection 2019.
PubMed 30809191Rankin A, O'Donovan C, Madigan SM, O'Sullivan O, Cotter PD. 'Microbes in sport' -The potential role of the gut microbiota in athlete health and performance. Br J Sports Med. 2017 May;51(9):698-699. doi: 10.1136/bjsports-2016-097227. Epub 2017 Jan 25. No abstract available.
PubMed 28432108Tornberg AB, Melin A, Koivula FM, Johansson A, Skouby S, Faber J, Sjodin A. Reduced Neuromuscular Performance in Amenorrheic Elite Endurance Athletes. Med Sci Sports Exerc. 2017 Dec;49(12):2478-2485. doi: 10.1249/MSS.0000000000001383.
PubMed 28723842Griffiths MD, Szabo A, Terry A. The exercise addiction inventory: a quick and easy screening tool for health practitioners. Br J Sports Med. 2005 Jun;39(6):e30. doi: 10.1136/bjsm.2004.017020.
PubMed 15911594Melin A, Tornberg AB, Skouby S, Faber J, Ritz C, Sjodin A, Sundgot-Borgen J. The LEAF questionnaire: a screening tool for the identification of female athletes at risk for the female athlete triad. Br J Sports Med. 2014 Apr;48(7):540-5. doi: 10.1136/bjsports-2013-093240. Epub 2014 Feb 21.
PubMed 24563388Lundy B, Torstveit MK, Stenqvist TB, Burke LM, Garthe I, Slater GJ, Ritz C, Melin AK. Screening for Low Energy Availability in Male Athletes: Attempted Validation of LEAM-Q. Nutrients. 2022 Apr 29;14(9):1873. doi: 10.3390/nu14091873.
PubMed 35565840Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S. Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry. 2015 Aug 5;15:190. doi: 10.1186/s12888-015-0529-3.
PubMed 26242577Lundgren T, Parling T. Swedish Acceptance and Action Questionnaire (SAAQ): a psychometric evaluation. Cogn Behav Ther. 2017 Jun;46(4):315-326. doi: 10.1080/16506073.2016.1250228. Epub 2016 Dec 9.
PubMed 27931161
Study at a glance
From the registry record, last updated by the sponsor on 10 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relative Energy Deficiency in Sports (REDs) in Swedish Athletes Study
- ClinicalTrials.gov ID
- NCT06371963
- Acronym / sponsor ID
- REDs-Sweden / LinnaeusU REDs
- Conditions
- RED S, Eating Disorders
- Keywords
- Observational study, REDs, Eating disorders, Cross-sectional study, Elite athletes, Sweden, Physiological assessments, Performance
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Linnaeus UniversityUniversity, hospital or other
- Collaborators
- Swedish Olympic Committee, Swedish Research Council for Sport Science, World Anti-Doping Agency
- Study start
- 10 May 2022 (actual)
- Primary completion
- 30 May 2024 (actual)
- Study completion
- 30 May 2024 (actual)
- First posted
- 17 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Relative Energy Deficiency in Sport (REDs) describes impairment of health and performance due to problematic (long-term/severe) low energy availability (LEA), with or without eating disorders. LEA is frequently reported in sports with high training volumes, especially in leanness demanding sports, and 20% of female and 9% of male Norwegian national team athletes have been reported to have eating disorders. Potential trigger factors are e.g., dieting, injuries, coaching behavior, and subculture aspects e.g., focus on low body weight. The main questions that will be addressed are: 1. What is the prevalence of eating disorders and REDs among Swedish elite athletes and controls? 2. What is the impact of problematic LEA on health and performance aspects in both male and female athletes? Methods: National team athletes and gender and matched controls will be invited to an anonymous on-line survey. Elite athletes who agree to participate, will be invited to assessment of eating disorders, nutritional and physiological status (e.g., metabolic and endocrine markers, bone health, microbiota, dietary intake, energy availability, and performance).
Detailed description
The syndrome of REDs describes impairment of physiological functions e.g., reproduction and bone health with negative impact on performance. The etiology behind is problematic low energy availability (LEA), defined as low energy intake relative to exercise energy expenditure relative to fat free mass. Eating disorders can either proceed or result from REDs. LEA induces metabolic and endocrine alterations, and energy balance at a lower level prevents further weight-loss. Therefore, most athletes with LEA have a body weight within the normal range, and low resting metabolic rate is a recognized LEA surrogate marker.
LEA suppresses anabolic hormones e.g. estradiol/testosterone, while cortisol levels increase, and bone formation markers are reduced. Low testosterone levels have been reported in male endurance athletes, with potential negative effects on fertility. Among Irish male athletes from different sports 23% were identified with low libido and associated with increased injury risk. Menstrual disturbances due to LEA is frequently reported, and is associated with low bone mineral density and injuries.
Glucose is an important substrate for the muscles and an essential substrate for brain neurons and immune cells. Low glucose availability is considered a major trigger to the alterations of the hypothalamic-pituitary axis hormones causing suppression of the sex and thyroid hormones and increase in cortisol. Blood glucose homeostasis is therefore protected with several mechanism (hepatic gluconeogenesis, increased lipolysis and ketogenesis) during prolonged LEA. Hence, hypoglycemia is a marker of a prolonged and severe catabolic state.
LEA has been associated with gastrointestinal problems in female athletes, derived from hormonal and dietary factors affecting motility and digestion. Long-term LEA in patients with anorexia nervosa is associated with profound alterations of the gut microbiome, with negative impact on gastrointestinal function and immunologic processes, and a reduced microbial diversity is therefore suggested as a potential useful biomarker of REDs in athletes. It is therefore relevant to investigate the associations between the gut microbiome, Gastrointestinal function and immunology status in athletes with and without clinical indication of LEA.
LEA affects both men and women, athletes as well as recreational active people however, the threshold and endocrine response seem to differ between gender. Although menstrual disturbances has been frequently reported in female athletes for decades, few studies have investigated the impact on performance, and no study has yet investigated the performance effects of low libido in male athletes. Furthermore, no study has investigated microbial diversity in male and female athletes with clinical symptoms of LEA. Therefore, it is highly relevant to investigate aspects of physiology, nutrition, performance, and sport environment regarding REDs and eating disorders in both male and females.
Objective: The aims of the study are to investigate the prevalence of athletes at risk of eating disorders and REDs among Swedish athletes and controls, and to investigate physiological aspects of elite athletes with and without problematic LEA. Furthermore, to investigate if there is a difference in nutritional status (metabolic and endocrine markers, iron- vitamin D status, energy availability, glucose homeostasis, resting metabolic rate, body composition including bone mineral density), gut microbiota (including associations to immunity), immune function, and performance, in athletes diagnosed with REDs according the International Olympic Committee REDs Clinical Assessment Tool vs. gender matched athletes without REDs. An additional aim is to evaluate if problematic LEA affects biological markers in the biological passport also called "Athlete Biological Passport" in anti-doping.
Methodology and plan of work National senior team and recruiting squad athletes from Swedish sport federations will be invited to an anonymous on-line survey. The 20 minute on-line survey includes: Eating Disorder Examination Questionnaire (EDE-Q). An EDE-Q global score ≥ 2.3 for females and ≥ 1.68 for males indicate risk of EDs; Exercise Addiction Inventory (EAI). A total EAI-score 24-30 indicate compulsive exercise; LEA in Females Questionnaire (LEAF-Q) and LEA in Males Questionnaire (LEAM-Q) to categorize athletes ar risk of LEA; Major Depression Inventory (MDI) to detect depression symptoms; Swedish Acceptance and Action Questionnaire (SAAQ) to assess psychological flexibility; and Motivation to Change Questionnaire (MCQ) to asses the ability for behavioral changes.
Participants who are interested in participating in an on-line diagnostic eating disorder examination interview (the EDE-16) and/or physiological testing, provide their name, cell-phone number, and e-mail address after completing the online survey, and will thereafter be invited to the sport physiology lab for the next phase of the study (physiological assessments).
On the day of the physiological examination, the participants will be asked to deliver a fecal sample. Gut microbiota composition bacterial DNA will be sequenced using next-generation sequencing of microbial genes.
Fasting resting metabolic rate will be measured, using a ventilated open hood system. The ration between measured and predicted resting metabolic will be calculated, and low resting metabolic rate will be defined as resting metabolic rate ratio < 0.90.
Blood samples will be collected and stored (-80°) for later analyses according to standard laboratory procedures (e.g. iron- and vitamin D status, hormones, metabolic, bone and immune markers).
Body weight, height (fixed stadiometer), fat free mass, fat mass and bone mineral density (whole body, femur, and lumbar spine) will be measured using dual-energy x-ray absorptiometry. Low bone mineral density will be defined as Z score -1 to -2 in at least one measured site and osteoporosis as Z-score ≤-2.
After a standardized meal and warm up, a bicycle ergometer exercise test will be performed (6 minutes at 50 watt, followed by 12-14 watt per minute increased workload until exhaustion). Heart rate and an air-tight mask covering the mouth and nose will be used to measure peak oxygen uptake. Capillary lactate will be drawn before, direct after and 5 minutes after the test. Explosive lower body power will be assessed through a counter movement jump-test. Isometric mid-thigh pull will be performed to assess whole body strength and force production. A Wingate-test will be performed to assess muscular power and anaerobic capacity. Post exercise blood-samples will be drawn and stored (-80°) for later analyses according to standard laboratory procedures (e.g., immune markers).
Participants will be asked to wear a subcutaneous continuous blood glucose monitor, an accelerometer, throughout the day except during training where they will wear heart rate monitors and register all training sessions in their home environment for 7 consecutive days. During 4 days in the the same period they will be asked to register all food intake using an electronic kitchen scale and an on-line nutrient program while information of energy and nutrient intake is blinded for the participants. Energy and nutrient intake will be calculated using a nutrient analysis program. Training heart rate and training logs will be used to assess exercise energy expenditure based on individual prediction equations from measured heart rate and corresponding energy expenditure during the peak oxygen uptake test. Energy availability will be calculated by subtracting mean exercise energy expenditure from mean energy intake relative to fat free mass.
Eumenorrheic athletes will be tested on day 2-6 of menstruation, while other athletes will be tested when convenient. All materials (electronic kitchen scale, heart rate monitor, fecal sample collective tube and a prepaid security envelops for returning materials) will be provided.
The skills and equipment for all assessments are available at the Linnaeus University including preparation, storage, and analysis of blood. Fecal samples will be analyzed at the Department of Nutrition, Exercise and Sport, University of Copenhagen.
Power calculation: to provide 80% power to detect a clinically relevant difference in sex hormones a minimum of 14 females (estradiol standard deviation 79.0 nmol/L) and 8 males (total testosterone standard deviation 7.4 pmol/L) in each group will be included.
Recruitment will be performed via the Swedish Olympic Committee, the national sport federations, and social media. The on-line surveys will be launched via the REDs Sweden project webpage and will be open March 2023 to June 2024. Recruitment of age and gender matched controls to the online survey will be performed via social media. Athletes who agree to participate in physiological testing will be continuously scheduled for tests and assessments.
Ethical reviews: The study will follow the checklist issued by the national committees for research ethics and the Helsinki Declaration. Ethical approval has been approved (2021-07031-01). All information and results will be coded (anonymized) before analysis and stored according the general data protection regulation. A list with codes connecting participant names and information will be kept safely locked in by the principal investigator at the Linnaeus University. There are no expected risks with participation. The radiation during the Dual-energy X-ray absorptiometry measurement is negligible. Participants may feel uncomfortable during the assessment of resting metabolic rate and blood sampling. The study collaborators will make sure that participants feel safe during all measurements. If a diagnosis is identified, participants will be referred to the health care system. Participants will be informed regarding ethical rights, the project, expected time cost for participation, and feedback on individual results.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Elite Athletes | – | –Senior Swedish male and female national team and recruiting squad athletes. |
| Gender and age matched controls | – | –Healthy male and female non-elite athletic controls. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Swedish male and female national team athletes and gender- and age matched controls.
Key inclusion criteria (2 listed)
- National-team level athletes
- Non-elite athletic controls
Key exclusion criteria (5 listed)
- chronic illness (e.g., diabetes, hypothyroidism)
- injury
- smoking
- pregnancy
- hormonal contraceptive use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Self-reported eating disorders
Time frame: Day one
Participants: Female and male elite athletes and age and gender matched controls. An on-line version of the Eating Disorder Examination Questionnaire (EDE-Q) will be used comprising of 28 items, 4 sub-scales (restrained eating, eating-, body-, and weight concerns), and a global score. An EDE-Q global score ≥ 2.3 for females and ≥1.7 for males indicate risk of eating disorder.
23 secondary outcomes
Eating disorders
Time frame: Through study completion, an average of 1 year
Self-reported reproductive function in females not using hormonal contraceptives
Time frame: Day one
Reproductive function in females not using hormonal contraceptives
Time frame: Through study completion, an average of 1 year
Self-reported reproductive function in males
Time frame: Day one
Reproductive function in males
Time frame: Through study completion, an average of 1 year
Gastrointestinal function
Time frame: Day one
Injury
Time frame: Day one
Self- reported symptoms of depression
Time frame: Day one
Compulsive exercise
Time frame: Day one
The motivation for behavioral changes
Time frame: Day one
Psychological flexibility
Time frame: Day one
Changes in immune markers from pre to post exercise
Time frame: Through study completion, an average of 1 year
Microbiota
Time frame: Through study completion, an average of 1 year
Dietary intake
Time frame: Through study completion, an average of 1 year
Maximal aerobic capacity
Time frame: Through study completion, an average of 1 year
Explosive lower body power
Time frame: Through through study completion, an average of 1 year
Whole body strength
Time frame: Through study completion, an average of 1 year
Muscular power
Time frame: Through study completion, an average of 1 year
Resting Metabolic Rate
Time frame: Through study completion, an average of 1 year
Body composition
Time frame: Through study completion, an average of 1 year
Body weight
Time frame: Through study completion, an average of 1 year
Body height
Time frame: Through study completion, an average of 1 year
Glucose levels
Time frame: Through study completion, an average of 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Mar 2025.
- Background: PubMed 37752011Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, Heikura IA, Melin A, Pensgaard AM, Stellingwerff T, Sundgot-Borgen JK, Torstveit MK, Jacobsen AU, Verhagen E, Budgett R, Engebretsen L, Erdener U. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023 Sep;57(17):1073-1097. doi: 10.1136/bjsports-2023-106994.
- Background: PubMed 24888644Melin A, Tornberg AB, Skouby S, Moller SS, Sundgot-Borgen J, Faber J, Sidelmann JJ, Aziz M, Sjodin A. Energy availability and the female athlete triad in elite endurance athletes. Scand J Med Sci Sports. 2015 Oct;25(5):610-22. doi: 10.1111/sms.12261. Epub 2014 May 30.
- Background: PubMed 29773536Mountjoy M, Sundgot-Borgen JK, Burke LM, Ackerman KE, Blauwet C, Constantini N, Lebrun C, Lundy B, Melin AK, Meyer NL, Sherman RT, Tenforde AS, Klungland Torstveit M, Budgett R. IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. Br J Sports Med. 2018 Jun;52(11):687-697. doi: 10.1136/bjsports-2018-099193. No abstract available.
- Background: PubMed 29252050Heikura IA, Uusitalo ALT, Stellingwerff T, Bergland D, Mero AA, Burke LM. Low Energy Availability Is Difficult to Assess but Outcomes Have Large Impact on Bone Injury Rates in Elite Distance Athletes. Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):403-411. doi: 10.1123/ijsnem.2017-0313. Epub 2018 Jun 12.
- Background: PubMed 33573862Lundy SD, Sangwan N, Parekh NV, Selvam MKP, Gupta S, McCaffrey P, Bessoff K, Vala A, Agarwal A, Sabanegh ES, Vij SC, Eng C. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur Urol. 2021 Jun;79(6):826-836. doi: 10.1016/j.eururo.2021.01.014. Epub 2021 Feb 8.
- Background: PubMed 28195945Hackney AC, Lane AR, Register-Mihalik J, O'leary CB. Endurance Exercise Training and Male Sexual Libido. Med Sci Sports Exerc. 2017 Jul;49(7):1383-1388. doi: 10.1249/MSS.0000000000001235.
- Background: PubMed 32245088Logue DM, Madigan SM, Melin A, Delahunt E, Heinen M, Donnell SM, Corish CA. Low Energy Availability in Athletes 2020: An Updated Narrative Review of Prevalence, Risk, Within-Day Energy Balance, Knowledge, and Impact on Sports Performance. Nutrients. 2020 Mar 20;12(3):835. doi: 10.3390/nu12030835.
- Background: PubMed 30809191Seitz J, Belheouane M, Schulz N, Dempfle A, Baines JF, Herpertz-Dahlmann B. The Impact of Starvation on the Microbiome and Gut-Brain Interaction in Anorexia Nervosa. Front Endocrinol (Lausanne). 2019 Feb 12;10:41. doi: 10.3389/fendo.2019.00041. eCollection 2019.
- Background: PubMed 28432108Rankin A, O'Donovan C, Madigan SM, O'Sullivan O, Cotter PD. 'Microbes in sport' -The potential role of the gut microbiota in athlete health and performance. Br J Sports Med. 2017 May;51(9):698-699. doi: 10.1136/bjsports-2016-097227. Epub 2017 Jan 25. No abstract available.
- Background: PubMed 28723842Tornberg AB, Melin A, Koivula FM, Johansson A, Skouby S, Faber J, Sjodin A. Reduced Neuromuscular Performance in Amenorrheic Elite Endurance Athletes. Med Sci Sports Exerc. 2017 Dec;49(12):2478-2485. doi: 10.1249/MSS.0000000000001383.
- Background: PubMed 15911594Griffiths MD, Szabo A, Terry A. The exercise addiction inventory: a quick and easy screening tool for health practitioners. Br J Sports Med. 2005 Jun;39(6):e30. doi: 10.1136/bjsm.2004.017020.
- Background: PubMed 24563388Melin A, Tornberg AB, Skouby S, Faber J, Ritz C, Sjodin A, Sundgot-Borgen J. The LEAF questionnaire: a screening tool for the identification of female athletes at risk for the female athlete triad. Br J Sports Med. 2014 Apr;48(7):540-5. doi: 10.1136/bjsports-2013-093240. Epub 2014 Feb 21.
- Eating Disorder Examination, EDITION 16.0D, (Fairburn, 2008)Link provided by the sponsor.
- The REDs Seden project Web SiteLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for RED S
Active, not recruitingObservational study
Triggers of Eating Disorders in Athletes
Eating Disorders
Recruiting
Unravelling Energy Issues Underpinning Low Energy Availability in High Performance Athletes
Relative Energy Deficiency in Sport
Enrolling by invitationObservational study
Urinary Incontinence and Low Energy Avaliability in Professional and Pre-professional Dancers: a Cross-sectional Study
Urinary Incontinence, RED-S
Not yet recruiting
Effects of Resistance Training on Women With Functional Hypothalamic Amenorrhea
Amenorrhea, Functional Hypothalamic Amenorrhea (FHA)
RecruitingObservational study
Low Energy Availability and Hypertension in Division I HBCU Athletes
Vascular Stiffness, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anna Melin, PhD principal investigator
Linnaeus University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of RED S and Eating Disorders, run by Linnaeus University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-reported eating disorders (time frame: Day one). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06371963, which also lists 19 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2025.